[{"start_date": "2025-07-01", "end_date": "2025-09-30", "filing_date": "2025-11-06", "acceptance_datetime": "2025-11-06T21:52:09Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2025", "cik": "0001377121", "sic": "2834", "tickers": ["PTGX"], "company_name": "Protagonist Therapeutics, Inc", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001104659-25-107816", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001104659-25-107816/files/ptgx-20250930x10q_htm.xml", "financials": {"balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 115264000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": 645437000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 586424000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities": {"value": 56251000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_liabilities": {"value": 11309000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_liabilities": {"value": 44942000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_liabilities": {"value": 39296000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "other_noncurrent_assets": {"value": 111164000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "accounts_payable": {"value": 5646000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "fixed_assets": {"value": 4100000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "assets": {"value": 701688000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 701688000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_parent": {"value": 645437000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}, "income_statement": {"preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "basic_average_shares": {"value": 63772332.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "research_and_development": {"value": 40003000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "revenues": {"value": 4712000.0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_earnings_per_share": {"value": -0.62, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_average_shares": {"value": 63772332.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_income_loss": {"value": -46421000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "other_operating_expenses": {"value": 11130000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss": {"value": -39339000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "costs_and_expenses": {"value": 44051000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_before_tax": {"value": -39339000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -39339000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -39339000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_earnings_per_share": {"value": -0.62, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "benefits_costs_expenses": {"value": 44051000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_parent": {"value": -39339000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_expenses": {"value": 51133000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -38799000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -38799000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -38799000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "other_comprehensive_income_loss_attributable_to_parent": {"value": 540000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -1937000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -58555000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -54833000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 5659000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 5659000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": -58555000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -1937000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -54833000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}}}, {"start_date": "2025-04-01", "end_date": "2025-06-30", "filing_date": "2025-08-06", "acceptance_datetime": "2025-08-06T20:22:14Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2025", "cik": "0001377121", "sic": "2834", "tickers": ["PTGX"], "company_name": "Protagonist Therapeutics, Inc", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-25-010534", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-25-010534/files/ptgx-20250630x10q_htm.xml", "financials": {"balance_sheet": {"noncurrent_assets": {"value": 115480000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "accounts_payable": {"value": 3249000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity": {"value": 668018000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_current_liabilities": {"value": 32258000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "assets": {"value": 718006000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 35507000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities": {"value": 49988000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "fixed_assets": {"value": 4108000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_assets": {"value": 602526000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_noncurrent_assets": {"value": 111372000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_parent": {"value": 668018000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities_and_equity": {"value": 718006000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}, "cash_flow_statement": {"net_cash_flow": {"value": 28955000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -28780000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 2925000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": 28955000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": 54810000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 2925000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": 54810000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -28780000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -100000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "other_comprehensive_income_loss": {"value": -34871000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -34871000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -34871000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"operating_expenses": {"value": 47587000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "research_and_development": {"value": 37036000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_parent": {"value": -34771000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -42041000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "diluted_earnings_per_share": {"value": -0.55, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "costs_and_expenses": {"value": 40145000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "benefits_costs_expenses": {"value": 40145000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "diluted_average_shares": {"value": 63510537.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "revenues": {"value": 5546000.0, "unit": "USD", "label": "Revenues", "order": 100}, "basic_earnings_per_share": {"value": -0.55, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -34771000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_tax_expense_benefit": {"value": 172000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "income_loss_from_continuing_operations_before_tax": {"value": -34599000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "other_operating_expenses": {"value": 10551000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss": {"value": -34771000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_average_shares": {"value": 63510537.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_loss_from_continuing_operations_after_tax": {"value": -34771000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}}}}, {"start_date": "2025-01-01", "end_date": "2025-03-31", "filing_date": "2025-05-06", "acceptance_datetime": "2025-05-06T21:04:48Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2025", "cik": "0001377121", "sic": "2834", "tickers": ["PTGX"], "company_name": "Protagonist Therapeutics, Inc", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-25-006530", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-25-006530/files/ptgx-20250331x10q_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow": {"value": 42404000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 11443000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": 125363000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": 42404000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 11443000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -94402000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": -94402000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": 125363000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -11488000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -11488000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss_attributable_to_parent": {"value": 167000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "other_comprehensive_income_loss": {"value": 167000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "balance_sheet": {"noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_liabilities": {"value": 35112000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 689052000.0, "unit": "USD", "label": "Equity", "order": 1400}, "assets": {"value": 742132000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 742132000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 605860000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "accounts_payable": {"value": 2917000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "fixed_assets": {"value": 3530000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_liabilities": {"value": 32195000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_parent": {"value": 689052000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 136272000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 53080000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_noncurrent_assets": {"value": 132742000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}}, "income_statement": {"net_income_loss": {"value": -11655000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_parent": {"value": -11655000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_average_shares": {"value": 62963806.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_expenses": {"value": 47631000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "revenues": {"value": 28321000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -11655000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -11655000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_average_shares": {"value": 62963806.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "other_operating_expenses": {"value": 11738000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "benefits_costs_expenses": {"value": 39976000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "basic_earnings_per_share": {"value": -0.19, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -19310000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "research_and_development": {"value": 35893000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_after_tax": {"value": -11655000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "diluted_earnings_per_share": {"value": -0.19, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "costs_and_expenses": {"value": 39976000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}}}}, {"start_date": "2024-07-01", "end_date": "2024-09-30", "filing_date": "2024-11-07", "acceptance_datetime": "2024-11-07T21:39:59Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2024", "cik": "0001377121", "sic": "2834", "tickers": ["PTGX"], "company_name": "Protagonist Therapeutics, Inc", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-24-014888", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-24-014888/files/ptgx-20240930x10q_htm.xml", "financials": {"balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "fixed_assets": {"value": 2468000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity": {"value": 531915000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": 531915000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities_and_equity": {"value": 603857000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 476769000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "accounts_payable": {"value": 3049000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_liabilities": {"value": 27364000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 71942000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 127088000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_current_liabilities": {"value": 41529000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "assets": {"value": 603857000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 44578000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_noncurrent_assets": {"value": 124620000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}}, "income_statement": {"operating_income_loss": {"value": -41453000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "benefits_costs_expenses": {"value": 38305000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_loss_from_continuing_operations_after_tax": {"value": -33210000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "costs_and_expenses": {"value": 38305000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_available_to_common_stockholders_basic": {"value": -33210000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_parent": {"value": -33210000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "revenues": {"value": 4675000.0, "unit": "USD", "label": "Revenues", "order": 100}, "basic_earnings_per_share": {"value": -0.54, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "diluted_earnings_per_share": {"value": -0.54, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 46128000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_average_shares": {"value": 61767934.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_tax_expense_benefit": {"value": -420000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss": {"value": -33210000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_average_shares": {"value": 61767934.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "research_and_development": {"value": 35970000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_before_tax": {"value": -33630000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "other_operating_expenses": {"value": 10158000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 12051000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -27863000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -208710000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": -208710000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 12051000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -27863000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": -224522000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -224522000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "comprehensive_income": {"other_comprehensive_income_loss_attributable_to_parent": {"value": 1585000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "comprehensive_income_loss": {"value": -31625000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -31625000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -31625000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}, {"start_date": "2024-04-01", "end_date": "2024-06-30", "filing_date": "2024-08-06", "acceptance_datetime": "2024-08-06T20:18:39Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2024", "cik": "0001377121", "sic": "2834", "tickers": ["PTGX"], "company_name": "Protagonist Therapeutics, Inc", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-24-011095", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-24-011095/files/ptgx-20240630x10q_htm.xml", "financials": {"income_statement": {"net_income_loss_attributable_to_parent": {"value": -30616000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_earnings_per_share": {"value": -0.5, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "operating_income_loss": {"value": -38793000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "basic_average_shares": {"value": 61305289.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "diluted_average_shares": {"value": 61305289.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss": {"value": -30616000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "revenues": {"value": 4167000.0, "unit": "USD", "label": "Revenues", "order": 100}, "other_operating_expenses": {"value": 9440000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "research_and_development": {"value": 33520000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "costs_and_expenses": {"value": 35459000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "benefits_costs_expenses": {"value": 35459000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -31292000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -30616000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_expenses": {"value": 42960000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_earnings_per_share": {"value": -0.5, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_after_tax": {"value": -30616000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_tax_expense_benefit": {"value": -676000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 2572000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": 268622000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 183075000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 2572000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": -88119000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": 268622000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": 183075000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -88119000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "balance_sheet": {"noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_liabilities": {"value": 41578000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_assets": {"value": 43704000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": 541324000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 1780000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "accounts_payable": {"value": 3629000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": 73305000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_noncurrent_assets": {"value": 41924000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 541324000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities_and_equity": {"value": 614629000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "assets": {"value": 614629000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_current_liabilities": {"value": 37949000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_assets": {"value": 570925000.0, "unit": "USD", "label": "Current Assets", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -30636000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -20000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "comprehensive_income_loss_attributable_to_parent": {"value": -30636000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -30636000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}}}, {"start_date": "2024-01-01", "end_date": "2024-03-31", "filing_date": "2024-05-07", "acceptance_datetime": "2024-05-07T20:51:57Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2024", "cik": "0001377121", "sic": "2834", "tickers": ["PTGX"], "company_name": "Protagonist Therapeutics, Inc", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-24-007081", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-24-007081/files/ptgx-20240331x10q_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 7199000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": -14159000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 6071000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -27429000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 7199000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": 6071000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": -14159000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -27429000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "balance_sheet": {"fixed_assets": {"value": 1111000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity": {"value": 560444000.0, "unit": "USD", "label": "Equity", "order": 1400}, "accounts_payable": {"value": 3507000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_noncurrent_assets": {"value": 612000, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_assets": {"value": 1723000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 560444000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_current_liabilities": {"value": 36403000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities_and_equity": {"value": 629276000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 68832000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_liabilities": {"value": 39910000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 629276000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 627553000.0, "unit": "USD", "label": "Current Assets", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss": {"value": 207216000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": 207216000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -124000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "other_comprehensive_income_loss": {"value": -124000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "income_statement": {"income_loss_from_continuing_operations_before_tax": {"value": 210666000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "benefits_costs_expenses": {"value": 44287000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss": {"value": 207340000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_expenses": {"value": 48644000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_earnings_per_share": {"value": 3.41, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "basic_average_shares": {"value": 60855689.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_after_tax": {"value": 207340000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "diluted_average_shares": {"value": 63595328.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "costs_and_expenses": {"value": 44287000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "other_operating_expenses": {"value": 14910000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "research_and_development": {"value": 33734000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_tax_expense_benefit": {"value": 3326000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_available_to_common_stockholders_basic": {"value": 207340000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_parent": {"value": 207340000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "revenues": {"value": 254953000.0, "unit": "USD", "label": "Revenues", "order": 100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "diluted_earnings_per_share": {"value": 3.26, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "operating_income_loss": {"value": 206309000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}}}}, {"start_date": "2023-10-01", "end_date": "2023-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2023", "cik": "0001377121", "sic": "2834", "tickers": ["PTGX"], "company_name": "Protagonist Therapeutics, Inc", "financials": {"cash_flow_statement": {"net_cash_flow": {"value": -43800000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 527000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": -61287000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 527000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -61287000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -43800000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": 16960000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": 16960000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 65000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": 27400000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": 27400000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss_attributable_to_parent": {"value": 65000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "income_statement": {"operating_income_loss": {"value": 23049000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_parent": {"value": 27335000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "diluted_average_shares": {"value": 1221016.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "diluted_earnings_per_share": {"value": 0.52, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss": {"value": 27335000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "revenues": {"value": 60000000.0, "unit": "USD", "label": "Revenues", "order": 100}, "research_and_development": {"value": 28899000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_average_shares": {"value": 1221016.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "operating_expenses": {"value": 36951000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": 27335000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "other_operating_expenses": {"value": 8052000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_before_tax": {"value": 27335000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_from_continuing_operations_after_tax": {"value": 27335000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_earnings_per_share": {"value": 0.52, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}}, "balance_sheet": {"other_noncurrent_assets": {"value": 1179000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "accounts_payable": {"value": 772000, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_liabilities": {"value": 20502000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_liabilities": {"value": 21274000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities": {"value": 21274000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": 336677000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 357951000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 355577000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "noncurrent_assets": {"value": 2374000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 336677000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "fixed_assets": {"value": 1195000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "assets": {"value": 357951000.0, "unit": "USD", "label": "Assets", "order": 100}}}}, {"start_date": "2023-07-01", "end_date": "2023-09-30", "filing_date": "2023-11-02", "acceptance_datetime": "2023-11-02T21:07:57Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2023", "cik": "0001377121", "sic": "2834", "tickers": ["PTGX"], "company_name": "Protagonist Therapeutics, Inc", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-23-017460", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-23-017460/files/ptgx-20230930x10q_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow": {"value": -4855000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": -13559000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": -13559000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -26611000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 35315000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -26611000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": -4855000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 35315000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -34077000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss_attributable_to_parent": {"value": 28000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -34077000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -34077000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "balance_sheet": {"equity": {"value": 302149000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 27867000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "accounts_payable": {"value": 1252000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_noncurrent_assets": {"value": 3714000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "other_current_liabilities": {"value": 26615000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "assets": {"value": 330016000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 1421000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_assets": {"value": 5135000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 330016000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_liabilities": {"value": 27867000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "current_assets": {"value": 324881000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_parent": {"value": 302149000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}, "income_statement": {"revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "other_operating_expenses": {"value": 7662000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "diluted_earnings_per_share": {"value": -0.58, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_continuing_operations_before_tax": {"value": -34105000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_income_loss": {"value": -38326000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 38326000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_parent": {"value": -34105000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "diluted_average_shares": {"value": 59182899.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "research_and_development": {"value": 30664000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_after_tax": {"value": -34105000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -34105000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -34105000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "basic_earnings_per_share": {"value": -0.58, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "basic_average_shares": {"value": 59182899.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}}}}, {"start_date": "2023-04-01", "end_date": "2023-06-30", "filing_date": "2023-08-03", "acceptance_datetime": "2023-08-03T20:21:30Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2023", "cik": "0001377121", "sic": "2834", "tickers": ["PTGX"], "company_name": "Protagonist Therapeutics, Inc", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-23-013245", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-23-013245/files/ptgx-20230630x10q_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss": {"value": -38536000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -38536000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -76000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "comprehensive_income_loss_attributable_to_parent": {"value": -38536000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"net_income_loss_available_to_common_stockholders_basic": {"value": -38460000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -38460000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -42354000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "basic_average_shares": {"value": 56775742.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "other_operating_expenses": {"value": 9172000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_parent": {"value": -38460000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 42354000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_earnings_per_share": {"value": -0.68, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_after_tax": {"value": -38460000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "research_and_development": {"value": 33182000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -38460000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "diluted_average_shares": {"value": 56775742.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "diluted_earnings_per_share": {"value": -0.68, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}}, "balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 26398000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_liabilities": {"value": 21825000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities_and_equity": {"value": 320466000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_parent": {"value": 294068000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 316941000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_noncurrent_assets": {"value": 2262000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "assets": {"value": 320466000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 3525000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "accounts_payable": {"value": 4573000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity": {"value": 294068000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 26398000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 1263000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 25762000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -26238000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 108172000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -26238000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 108172000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 25762000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 107696000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 107696000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}}}, {"start_date": "2023-01-01", "end_date": "2023-03-31", "filing_date": "2023-05-04", "acceptance_datetime": "2023-05-04T20:33:52Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2023", "cik": "0001377121", "sic": "2834", "tickers": ["PTGX"], "company_name": "Protagonist Therapeutics, Inc", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-23-008137", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-23-008137/files/ptgx-20230331x10q_htm.xml", "financials": {"comprehensive_income": {"other_comprehensive_income_loss": {"value": 237000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -33488000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -33488000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss_attributable_to_parent": {"value": 237000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"other_current_liabilities": {"value": 19208000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_assets": {"value": 235736000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities": {"value": 23691000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_noncurrent_assets": {"value": 2781000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_assets": {"value": 4122000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_liabilities": {"value": 23229000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 239858000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "assets": {"value": 239858000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 1341000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_parent": {"value": 216167000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 216167000.0, "unit": "USD", "label": "Equity", "order": 1400}, "accounts_payable": {"value": 4021000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -34347000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": 9826000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": 1942000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 26463000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 26463000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -34347000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": 1942000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": 9826000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "income_statement": {"revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -33725000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss": {"value": -33725000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_earnings_per_share": {"value": -0.67, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_average_shares": {"value": 50573650.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_attributable_to_parent": {"value": -33725000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": -33725000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_available_to_common_stockholders_basic": {"value": -33725000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_income_loss": {"value": -36021000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "research_and_development": {"value": 27416000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "diluted_average_shares": {"value": 50573650.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "basic_earnings_per_share": {"value": -0.67, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 36021000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "other_operating_expenses": {"value": 8605000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}}}}, {"start_date": "2022-10-01", "end_date": "2022-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2022", "cik": "0001377121", "sic": "2834", "tickers": ["PTGX"], "company_name": "Protagonist Therapeutics, Inc", "financials": {"cash_flow_statement": {"net_cash_flow_continuing": {"value": -27147000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -31635000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -27072000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 3935000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "exchange_gains_losses": {"value": 75000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_financing_activities": {"value": 553000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": 3935000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -31635000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 553000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "income_statement": {"operating_income_loss": {"value": -36516000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 36516000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_parent": {"value": -34194000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "basic_average_shares": {"value": 70903, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "other_operating_expenses": {"value": 6632000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -34194000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_after_tax": {"value": -34194000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss": {"value": -34194000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "benefits_costs_expenses": {"value": 34194000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "diluted_earnings_per_share": {"value": -0.7000000000000002, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_continuing_operations_before_tax": {"value": -34194000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "research_and_development": {"value": 29884000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "diluted_average_shares": {"value": 70903, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "basic_earnings_per_share": {"value": -0.7000000000000002, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "costs_and_expenses": {"value": 34194000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}}, "comprehensive_income": {"other_comprehensive_income_loss_attributable_to_parent": {"value": 121000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -34073000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 121000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -34073000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "balance_sheet": {"liabilities_and_equity": {"value": 247928000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 4851000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_liabilities": {"value": 31179000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_noncurrent_assets": {"value": 3286000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "other_current_liabilities": {"value": 27539000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "fixed_assets": {"value": 1565000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_assets": {"value": 243077000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 1141000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 215608000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": 215608000.0, "unit": "USD", "label": "Equity", "order": 1400}, "accounts_payable": {"value": 3640000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "assets": {"value": 247928000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 32320000.0, "unit": "USD", "label": "Liabilities", "order": 600}}}}, {"start_date": "2022-07-01", "end_date": "2022-09-30", "filing_date": "2022-11-08", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2022", "cik": "0001377121", "sic": "2834", "tickers": ["PTGX"], "company_name": "Protagonist Therapeutics, Inc", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-22-016908", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-22-016908/files/ptgx-20220930x10q_htm.xml", "financials": {"balance_sheet": {"liabilities_and_equity": {"value": 282174000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 243616000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 36754000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 282174000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_assets": {"value": 276617000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities": {"value": 38558000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "fixed_assets": {"value": 1783000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_liabilities": {"value": 32039000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_liabilities": {"value": 1804000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "accounts_payable": {"value": 4715000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_parent": {"value": 243616000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_noncurrent_assets": {"value": 3774000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_assets": {"value": 5557000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -30992000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -30992000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -30992000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss_attributable_to_parent": {"value": 240000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}}, "income_statement": {"research_and_development": {"value": 25402000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -31232000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "diluted_earnings_per_share": {"value": -0.64, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_expenses": {"value": 32303000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_average_shares": {"value": 49107639.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_loss_from_continuing_operations_before_tax": {"value": -31232000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "other_operating_expenses": {"value": 6901000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "benefits_costs_expenses": {"value": 31232000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_loss_from_continuing_operations_after_tax": {"value": -31232000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_earnings_per_share": {"value": -0.64, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss": {"value": -31232000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -32303000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_average_shares": {"value": 49107639.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_parent": {"value": -31232000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "costs_and_expenses": {"value": 31232000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 680000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": 57275000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": 57275000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 680000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -25201000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "exchange_gains_losses": {"value": -175000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_operating_activities": {"value": -25201000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": 32579000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": 32754000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}}}, {"start_date": "2022-04-01", "end_date": "2022-06-30", "filing_date": "2022-08-04", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2022", "cik": "0001377121", "sic": "2834", "tickers": ["PTGX"], "company_name": "Protagonist Therapeutics, Inc", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-22-012277", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-22-012277/files/ptgx-20220630x10q_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_continuing": {"value": 21779000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -13635000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 680000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": 34734000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 34734000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -13635000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "exchange_gains_losses": {"value": -19000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow": {"value": 21760000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 680000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "income_statement": {"diluted_earnings_per_share": {"value": -0.84, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "other_operating_expenses": {"value": 7691000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "revenues": {"value": 859000, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss": {"value": -41037000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_income_loss": {"value": -41443000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "basic_average_shares": {"value": 49049902.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_loss_from_continuing_operations_after_tax": {"value": -41037000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_loss_from_continuing_operations_before_tax": {"value": 859000, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "diluted_average_shares": {"value": 49049902.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_expenses": {"value": 42302000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "research_and_development": {"value": 34611000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_earnings_per_share": {"value": -0.84, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_parent": {"value": -41037000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "costs_and_expenses": {"value": 42302000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_available_to_common_stockholders_basic": {"value": -41037000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -41285000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -41285000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -41285000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -248000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"noncurrent_assets": {"value": 6210000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "fixed_assets": {"value": 1962000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "assets": {"value": 310512000.0, "unit": "USD", "label": "Assets", "order": 100}, "accounts_payable": {"value": 1412000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities_and_equity": {"value": 310512000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_parent": {"value": 267978000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 40088000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "current_assets": {"value": 304302000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_noncurrent_assets": {"value": 4248000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity": {"value": 267978000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_current_liabilities": {"value": 38676000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities": {"value": 42534000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}}}, {"start_date": "2022-01-01", "end_date": "2022-03-31", "filing_date": "2022-05-05", "acceptance_datetime": "2022-05-05T20:50:45Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2022", "cik": "0001377121", "sic": "2834", "tickers": ["PTGX"], "company_name": "Protagonist Therapeutics, Inc", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-22-007438", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-22-007438/files/ptgx-20220331x10q_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": -4476000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 16925000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 16925000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -37666000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -25188000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "exchange_gains_losses": {"value": 29000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_investing_activities": {"value": -4476000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -37666000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": -25217000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "balance_sheet": {"current_liabilities": {"value": 43456000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "accounts_payable": {"value": 7159000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity": {"value": 301778000.0, "unit": "USD", "label": "Equity", "order": 1400}, "assets": {"value": 348296000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 301778000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "fixed_assets": {"value": 2064000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_noncurrent_assets": {"value": 4710000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "liabilities": {"value": 46518000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_liabilities": {"value": 36297000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 341522000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 6774000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 348296000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}}, "income_statement": {"diluted_earnings_per_share": {"value": -0.43, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_continuing_operations_before_tax": {"value": -20930000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "revenues": {"value": 25722000.0, "unit": "USD", "label": "Revenues", "order": 100}, "other_operating_expenses": {"value": 10515000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "diluted_average_shares": {"value": 48752548.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_expenses": {"value": 46833000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_after_tax": {"value": -20930000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -20930000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_parent": {"value": -20930000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss": {"value": -20930000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_earnings_per_share": {"value": -0.43, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "costs_and_expenses": {"value": 46652000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "basic_average_shares": {"value": 48752548.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "operating_income_loss": {"value": -21111000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "research_and_development": {"value": 36318000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "benefits_costs_expenses": {"value": 46652000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -173000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -21103000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -21103000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -173000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}}}}, {"start_date": "2021-10-01", "end_date": "2021-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2021", "cik": "0001377121", "sic": "2834", "tickers": ["PTGX"], "company_name": "Protagonist Therapeutics, Inc", "financials": {"income_statement": {"net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -36907000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss": {"value": -36907000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "other_operating_expenses": {"value": 7260000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "income_loss_from_continuing_operations_after_tax": {"value": -36907000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_parent": {"value": -36907000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_expenses": {"value": 45633000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 8617000.0, "unit": "USD", "label": "Revenues", "order": 100}, "benefits_costs_expenses": {"value": 45524000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -36907000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_income_loss": {"value": -37016000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "research_and_development": {"value": 38373000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "costs_and_expenses": {"value": 45524000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 27867000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 27867000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -26939000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 2173000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 3123000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 2173000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "exchange_gains_losses": {"value": 22000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_continuing": {"value": 3101000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -26939000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "balance_sheet": {"fixed_assets": {"value": 1798000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_assets": {"value": 340736000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 44016000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 300021000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "accounts_payable": {"value": 1600000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_assets": {"value": 6959000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 47674000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_noncurrent_assets": {"value": 5161000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "other_current_liabilities": {"value": 42416000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity": {"value": 300021000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 3658000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 347695000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "assets": {"value": 347695000.0, "unit": "USD", "label": "Assets", "order": 100}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -37002000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -37002000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -95000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -95000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}}}}, {"start_date": "2021-07-01", "end_date": "2021-09-30", "filing_date": "2021-11-03", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2021", "cik": "0001377121", "sic": "2834", "tickers": ["PTGX"], "company_name": "Protagonist Therapeutics, Inc", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-21-014338", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-21-014338/files/ptgx-20210930x10q_htm.xml", "financials": {"balance_sheet": {"equity_attributable_to_parent": {"value": 329660000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 4359000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 327687000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 45488000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "assets": {"value": 373175000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 39156000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 43515000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_liabilities": {"value": 38450000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "other_noncurrent_assets": {"value": 43765000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "fixed_assets": {"value": 1723000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities_and_equity": {"value": 373175000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 329660000.0, "unit": "USD", "label": "Equity", "order": 1400}, "accounts_payable": {"value": 706000, "unit": "USD", "label": "Accounts Payable", "order": 710}}, "income_statement": {"costs_and_expenses": {"value": 44090000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_before_tax": {"value": -33804000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "research_and_development": {"value": 36956000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "revenues": {"value": 10286000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_after_tax": {"value": -33804000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "operating_expenses": {"value": 44212000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "other_operating_expenses": {"value": 7256000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_parent": {"value": -33804000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -33804000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_income_loss": {"value": -33926000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "benefits_costs_expenses": {"value": 44090000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss": {"value": -33804000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 1381000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -28470000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": -71796000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": -44707000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": -71870000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -28470000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 1381000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": -44707000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "exchange_gains_losses": {"value": -74000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -33949000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -145000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "comprehensive_income_loss": {"value": -33949000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -33949000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"start_date": "2021-04-01", "end_date": "2021-06-30", "filing_date": "2021-08-04", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2021", "cik": "0001377121", "sic": "2834", "tickers": ["PTGX"], "company_name": "Protagonist Therapeutics, Inc", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-21-010244", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-21-010244/files/ptgx-20210630x10q_htm.xml", "financials": {"balance_sheet": {"liabilities_and_equity": {"value": 404232000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_noncurrent_assets": {"value": 30696000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_current_liabilities": {"value": 35068000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "assets": {"value": 404232000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_parent": {"value": 357447000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 32414000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": 357447000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 46785000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_liabilities": {"value": 42973000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 1718000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "accounts_payable": {"value": 7905000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 371818000.0, "unit": "USD", "label": "Current Assets", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -30868000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -30868000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -30868000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -26000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}}, "cash_flow_statement": {"exchange_gains_losses": {"value": -51000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_investing_activities_continuing": {"value": 7773000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -23700000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -23700000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": 109463000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 125390000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 125390000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 109412000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 7773000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "income_statement": {"income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss": {"value": -30842000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -30842000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "revenues": {"value": 2265000.0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_income_loss": {"value": -30882000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "research_and_development": {"value": 26432000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "benefits_costs_expenses": {"value": 33107000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "other_operating_expenses": {"value": 6715000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 33147000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_before_tax": {"value": -30842000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "costs_and_expenses": {"value": 33147000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_parent": {"value": -30842000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": -30842000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}}}}, {"start_date": "2021-01-01", "end_date": "2021-03-31", "filing_date": "2021-05-04", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2021", "cik": "0001377121", "sic": "2834", "tickers": ["PTGX"], "company_name": "Protagonist Therapeutics, Inc", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-21-005733", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-21-005733/files/ptgx-20210331x10q_htm.xml", "financials": {"income_statement": {"net_income_loss_available_to_common_stockholders_basic": {"value": -23998000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "benefits_costs_expenses": {"value": 30187000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_parent": {"value": -23998000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss": {"value": -23998000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_expenses": {"value": 30210000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "operating_income_loss": {"value": -24021000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "research_and_development": {"value": 24245000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "costs_and_expenses": {"value": 30210000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "revenues": {"value": 6189000.0, "unit": "USD", "label": "Revenues", "order": 100}, "other_operating_expenses": {"value": 5965000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_after_tax": {"value": -23998000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_loss_from_continuing_operations_before_tax": {"value": -23998000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": -6793000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -28756000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -6793000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "exchange_gains_losses": {"value": -23000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_financing_activities": {"value": 979000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -28756000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 979000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": -34570000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -34593000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "balance_sheet": {"other_noncurrent_assets": {"value": 11132000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_assets": {"value": 285508000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 34515000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_assets": {"value": 12564000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 259334000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities_and_equity": {"value": 298072000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "fixed_assets": {"value": 1432000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 259334000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 38738000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "assets": {"value": 298072000.0, "unit": "USD", "label": "Assets", "order": 100}, "accounts_payable": {"value": 2732000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_liabilities": {"value": 31783000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -24059000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -61000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "comprehensive_income_loss_attributable_to_parent": {"value": -24059000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -61000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"start_date": "2020-10-01", "end_date": "2020-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2020", "cik": "0001377121", "sic": "2834", "tickers": ["PTGX"], "company_name": "Protagonist Therapeutics, Inc", "financials": {"comprehensive_income": {"other_comprehensive_income_loss_attributable_to_parent": {"value": 116000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "comprehensive_income_loss": {"value": -18770000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 116000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -18770000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "income_statement": {"net_income_loss_attributable_to_parent": {"value": -18886000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "income_loss_from_continuing_operations_after_tax": {"value": -18886000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "research_and_development": {"value": 19486000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "operating_expenses": {"value": 24480000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss": {"value": -18886000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "other_operating_expenses": {"value": 4994000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "benefits_costs_expenses": {"value": 24536000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -18886000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "costs_and_expenses": {"value": 24480000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "interest_expense_operating": {"value": 127000, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "income_loss_from_continuing_operations_before_tax": {"value": -18886000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_income_loss": {"value": -18830000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "revenues": {"value": 5650000.0, "unit": "USD", "label": "Revenues", "order": 100}}, "balance_sheet": {"equity": {"value": 279606000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 315606000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 324468000.0, "unit": "USD", "label": "Assets", "order": 100}, "accounts_payable": {"value": 3075000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_noncurrent_assets": {"value": 7400000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_assets": {"value": 8862000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_current_liabilities": {"value": 37166000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities_and_equity": {"value": 324468000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_parent": {"value": 279606000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 4621000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 1462000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities": {"value": 44862000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_liabilities": {"value": 40241000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}, "cash_flow_statement": {"exchange_gains_losses": {"value": 21000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_investing_activities_continuing": {"value": -74402000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": -74402000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 126981000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -18867000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": 33712000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 33733000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -18867000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 126981000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}}}, {"start_date": "2020-07-01", "end_date": "2020-09-30", "filing_date": "2020-11-04", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2020", "cik": "0001377121", "sic": "2834", "tickers": ["PTGX"], "company_name": "Protagonist Therapeutics, Inc", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-20-012597", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-20-012597/files/ptgx-20200930x10q_htm.xml", "financials": {"balance_sheet": {"accounts_payable": {"value": 2797000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_liabilities": {"value": 35766000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "other_noncurrent_assets": {"value": 11710000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_assets": {"value": 204151000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 13169000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "fixed_assets": {"value": 1459000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities_and_equity": {"value": 217320000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 38563000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 169590000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 9167000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 217320000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 47730000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": 169590000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}, "comprehensive_income": {"other_comprehensive_income_loss_attributable_to_parent": {"value": 120000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "comprehensive_income_loss": {"value": -7643000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -7643000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -7643000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 7669000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -16287000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 7669000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -54122000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": -54122000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -16287000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": -62740000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "exchange_gains_losses": {"value": 123000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow": {"value": -62617000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "income_statement": {"operating_expenses": {"value": 20886000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_after_tax": {"value": -7763000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "benefits_costs_expenses": {"value": 20877000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "costs_and_expenses": {"value": 20886000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss": {"value": -7763000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "revenues": {"value": 13114000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -7763000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_before_tax": {"value": -7763000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "other_operating_expenses": {"value": 4891000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "research_and_development": {"value": 15995000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "operating_income_loss": {"value": -7772000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_parent": {"value": -7763000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "interest_expense_operating": {"value": 19000, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}}}}]